Jennifer Sugarman

Jennifer Sugarman is an experienced clinical trial manager with a strong background in managing Phase 1 to Phase 3 clinical studies, particularly in ophthalmology and various therapeutic areas. Currently serving as a Sr. Clinical Trial Manager at EyePoint Pharmaceuticals since May 2022, Jennifer has previously held key positions at Galapagos as a Sr. Clinical Study Lead, and at AGTC and pSivida/Eyepoint Pharmaceuticals in clinical trial management roles. With a focus on overseeing CROs and developing standard operating procedures, protocols, and quality assurance documents, Jennifer has demonstrated expertise in ensuring compliance with regulatory requirements and the successful execution of clinical trials across multiple organizations. Jennifer holds a Master of Public Health from Boston University and a Bachelor of Arts in Psychology from Keene State College.